Cureline Group - Global Translational CRO’s Post

Cureline and Memel Biotech is at the SBD-2024 in Basel! Dr Olga Potapova, CEO of Cureline Group, and Agne Vaitkeviciene, CEO of Memel Biotech and COO of Cureline Baltic, are meeting with other startups, clients and suppliers from all over the world.

To view or add a comment, sign in

Explore topics